Bacterial endotoxins have been defined as integral components of the outer cell membrane of virtually all gram negative bacteria. When released from the organism during the course of bacterial infections, these potent bacterial products have an almost unlimited capacity to interact with mammalian cells and tissues. The consequences of these interactions may be extremely deleterious to the host and can result in fever, hypotension and disseminated intravascular coagulation. These characteristic manifestations of severe gram negative infections define a clinical state termed endotoxin shock. In this respect, endotoxin has been suggested to be one of the major contributing factors to the high incidence of mortality in gram negative bacteremia and sepsis, estimated to be as high as twenty thousand individuals annually in the United States alone. Intensive investigations during the past several decades have identified the lipopolysaccharide component of endotoxin, and more specifically the lipid A region of lipopolysaccharide, as an important biochemical element for the expression of endotoxin activity. However, the broad spectrum of biological activities of lipopolysaccharide/endotoxin has precluded a precise delineation of those interactions which are critical for manifestation of host tissue injury. In addition, in those cells which have been documented to recognize and respond to lipopolysaccharide, such as lymphocytes and macrophages, the mechanism by which these cells are triggered by lipopolysaccharide is completely unknown. Experiments outlined in this proposal have been designed to explore the concept of specific endotoxin receptors on the membranes of such cells. For these studies we will utilize extensively a mutant mouse strain, termed the C3H/HeJ strain, which is refractory to virtually all of the immunostimulatory and pathophysiologic effects of endotoxin, both in vitro and in vivo. The proposed research will employ both biochemical and immunologic techniques to define the molecular basis for endotoxin unresponsiveness of this C3H/HeJ mouse at the cellular level. These studies will contribute to our understanding of molecular interactions of endotoxin with mammalian cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI023447-01
Application #
3135520
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1986-01-01
Project End
1989-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Kansas
Department
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Qureshi, Nilofer; Vogel, Stefanie N; Van Way 3rd, Charles et al. (2005) The proteasome: a central regulator of inflammation and macrophage function. Immunol Res 31:243-60
Qureshi, Nilofer; Perera, Pin-Yu; Shen, Jing et al. (2003) The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J Immunol 171:1515-25
Gao, J J; Xue, Q; Zuvanich, E G et al. (2001) Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect Immun 69:751-7
Gao, J J; Xue, Q; Papasian, C J et al. (2001) Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J Immunol 166:6855-60
Luchi, M; Morrison, D C (2000) Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria. Infect Immun 68:1899-904
Gao, J J; Zuvanich, E G; Xue, Q et al. (1999) Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 163:4095-9
Norimatsu, M; Morrison, D C (1998) Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo. J Infect Dis 177:1302-7
Bucklin, S E; Morrison, D C (1996) Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy. J Infect Dis 174:1249-54
Bucklin, S E; Morrison, D C (1995) Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. J Infect Dis 172:1519-27
Chen, T Y; Lei, M G; Suzuki, T et al. (1992) Lipopolysaccharide receptors and signal transduction pathways in mononuclear phagocytes. Curr Top Microbiol Immunol 181:169-88

Showing the most recent 10 out of 26 publications